首页> 外文期刊>Pediatric cardiology >Amiodarone in a newborn with ventricular tachycardia and an intracardiac tumor: adjusting the dose according to an individualized dosing regimen.
【24h】

Amiodarone in a newborn with ventricular tachycardia and an intracardiac tumor: adjusting the dose according to an individualized dosing regimen.

机译:患有室性心动过速和心内瘤的新生儿中的胺碘酮:根据个体用药方案调整剂量。

获取原文
获取原文并翻译 | 示例
           

摘要

We report the successful management of recurrent ventricular tachycardias in a newborn suffering from an intracardiac tumor. Amiodarone was the only agent able to control the tachycardias and did so as long as an individually titrated plasma concentration above 0.8 mu mol/L was maintained. Because no therapeutic plasma concentration has been defined in children and no kinetic studies are available in this population, we optimized the dosing regimen based on a computer simulation, taking into account the pharmacokinetic parameters of the patient and the individual concentration-effect relation.
机译:我们报告了患有心内肿瘤的新生儿复发性室性心动过速的成功管理。胺碘酮是唯一能够控制心动过速的药物,只要维持单独滴定的血浆浓度在0.8μmol / L以上即可。由于尚未在儿童中定义治疗性血浆浓度,并且在该人群中尚无动力学研究,因此,我们基于计算机模拟优化了给药方案,同时考虑了患者的药代动力学参数和个体的浓度-效应关系。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号